STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)												1 Months Ended					3 Months Ended		12 Months Ended
	Mar. 17, 2021	Feb. 24, 2021	Feb. 24, 2021	Feb. 11, 2021	Jan. 25, 2021	Nov. 22, 2020	Sep. 25, 2020	Jul. 21, 2020	Jul. 06, 2020	Jun. 17, 2020	Feb. 05, 2020	Feb. 28, 2021	Dec. 31, 2020	Sep. 30, 2020	Jul. 31, 2020	Apr. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jul. 22, 2020	Jul. 08, 2020	Jun. 19, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value													$ 0.0001				$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Cash proceeds																			$ 58,269,829	$ 39,855,788
Shares issued during conversion
Shares issued for exercised stock options																			$ 1,506,999	16,669
Common Stock, Shares Subscribed but Unissued																	43,000		43,000
Share based compensation																			$ 7,556,282	$ 1,827,008
Preferred stock, shares authorized													20,000,000				20,000,000	20,000,000	20,000,000	20,000,000
Warrant exercise price													$ 8.03				$ 7.37	$ 8.03	$ 7.37	$ 8.03				$ 7.33
Warrants outstanding													3,501,014				6,108,823	3,501,014	6,108,823	3,501,014				461,647
Expected volatility																				89.76%
Risk-free interest rate																				0.38%
Advisors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																				1,037,496
Merger Sub [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																				2,337,663
Value of common stock issued																				$ 3,060,740
Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested																			1,158,891
Restricted Stock [Member] | Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																				1,087,618
Weighted average price restricted stock													$ 5.27					$ 5.27		$ 5.27
Share based compensation																	$ 6,323,880
Share based compensation																			$ 2,684,371
Restricted Stock [Member] | 2020 Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested																			1,201,891
Restricted Stock [Member] | Core IR [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued													15,000
Restricted Stock [Member] | Core IR [Member] | General and Administrative Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Offering expenses																				$ 42,300
Restricted Stock [Member] | Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested														15,115						15,115
Number of restricted stock units														436,368
Restricted Stock [Member] | Directors [Member] | 2020 Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of restricted stock units		172,000
Offering price		$ 7.66	$ 7.66
Restricted Stock [Member] | Director [Member] | 2020 Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of restricted stock units			172,000
Offering price		$ 7.66	$ 7.66
Restricted Stock [Member] | Chief Executive Officer [Member] | 2020 Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested																			434,166
Series H-3 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	2,800		2,800
Conversion price per share																	$ 165.60		$ 165.60
Warrant exercise price																	$ 165.60		$ 165.60
Warrants term																	5 years		5 years
Warrants outstanding																	2,800		2,800
AYRO Seed Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	461,647		461,647
Warrant exercise price																	$ 7.33		$ 7.33
Warrants term																	5 years		5 years
Warrants outstanding																	448,005		448,005
[custom:WarrantExpense-0]													$ 36,760				$ 0	$ 36,760	$ 0	$ 36,760
Series I Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	14,636		14,636
Warrant exercise price																	$ 69.00		$ 69.00
Warrants outstanding																	14,636		14,636
Warrants description																			If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise. During the year ended December 31, 2021, all 14,636 Series I Warrants expired
Warrant weighted average exercise price																	$ 138.00		$ 138.00
Series H-4 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price																	$ 15.60		$ 15.60
Warrants outstanding																	37,453		37,453
Anti-dilution price protection price per share																	$ 15.60		$ 15.60
Series J Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	52,023		52,023
Warrant exercise price																	$ 30.00		$ 30.00
Warrants outstanding																	52,023		52,023
Warrants description																			If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise
Exceeds warrant price per share																	$ 45.00		$ 45.00
Series H-5 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Offering price																	$ 2.77		$ 2.77
Warrants to purchase common stock																	296,389		296,389
Warrant exercise price																	$ 2.50		$ 2.50
Warrants term																	5 years		5 years
Warrants outstanding																	348,476		348,476
Warrants description																			The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share
Deemed dividend																			$ 432,727
Fair value of warrants																			967,143
Fair value of modification of orinigal award																			$ 534,416
Expected volatility																			89.96%
Dividend yield																			0.00%
Risk-free interest rate																			0.24%
Series I, H-1, H-3, H-4, J and H-5 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant expiration description																			Warrants expire through the years 2022-2024
June Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																							27,273
Warrant exercise price																							$ 2.75
Warrants term																							5 years
Warrants outstanding																	27,273		27,273
June Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	126,000		126,000				126,000
Warrant exercise price																							$ 2.875
July 8 Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	71,770		71,770			71,770
Warrant exercise price																						$ 5.225
July 8 Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	147,368		147,368			147,368
Warrant exercise price																						$ 5.4625
Warrants term																						5 years
July 22 Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																	129,500		129,500		129,500
Warrant exercise price																					$ 5.750
Warrants term																					5 years
September Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock							31,348										31,348		31,348
Share based compensation																		$ 66,845
Warrant exercise price							$ 3.19
Warrant expiration description							The September Warrant is immediately exercisable and expires on September 25, 2025
Decrease in exercise price							$ 2.13
November Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						56,256
Warrant exercise price						$ 6.6660
November Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						57,756
Warrant exercise price						$ 6.9690
Warrants description						The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025
February Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock				15,574													51,459		51,459
Warrant exercise price				$ 10.925
February Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock				255,584													255,584		255,584
Warrants term				5 years
Series H-6 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock shares issued															225,590
Conversion of stock shares															7,833
Series H-3 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock stated value																	$ 138.00		$ 138.00
Aggregate issued and outstanding shares percentage																	9.99%		9.99%
Series H Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock stated value																	$ 154.00		$ 154.00
Preferred stock, conversion price																			$ 184.80
Aggregate issued and outstanding shares percentage																	9.99%		9.99%
Series H-6 Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock stated value											$ 72.00
Preferred stock, conversion price											$ 3.60								$ 3.60
Aggregate issued and outstanding shares percentage											9.99%
Preferred stock, shares authorized											50,000
Preferred stock, conversion price description											Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																				5,074,645
Warrants to purchase common stock													5,092,806					5,092,806		5,092,806
Cash proceeds																				$ 3,926,818
Shares issued during conversion, shares																				2,007,193
Shares issued during conversion																				$ 201
Shares issued for exercised stock options																			$ 55
Shares issued for exercised stock options, shares																			555,004	6,817
Common Stock [Member] | Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Shares Subscribed but Unissued																	43,000		43,000
Common Stock [Member] | February Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock				35,885
Warrant exercise price				$ 10.45
Common Stock [Member] | Series H-3 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock shares issued																				795
AYRO Seed Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																				2,007,193
Shares issued during conversion, shares																				7,360,985
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock shares issued																			2,007,193
Conversion of stock shares																			7,360,985
Preferred stock, shares authorized													8,472,500				8,472,500	8,472,500	8,472,500	8,472,500
Preferred Stock [Member] | Series H-3 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock shares																				955
Preferred Stock [Member] | Series H Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued for exercised stock options
Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued				4,400,001
Proceeds from sale of common stock				$ 41,800,008	$ 20,000,004			$ 1,512,500
Offering expenses				$ 3,394,054	$ 1,648,608
Warrants to purchase common stock					233,334												3,566,668		3,566,668
Shares issued for exercised stock options												$ 100,000							$ 1,506,999
Shares issued for exercised stock options, shares																			555,004
Warrant exercise price					$ 6.93
Securities Purchase Agreement [Member] | January 2021 Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					3,333,334
Warrant exercise price					$ 6.93
Securities Purchase Agreement [Member] | Series A Warrants and Series B [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Value of common stock issued						$ 9,999,997
Securities Purchase Agreement [Member] | Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						1,237,624
Warrant exercise price						$ 8.09
Warrant expiration date						May 24, 2021
Securities Purchase Agreement [Member] | Series B Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						825,084											825,084		825,084
Warrant exercise price						$ 8.90
Warrants description						terminate five years from the date issuance on November 24, 2025
Securities Purchase Agreement [Member] | Additional Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued						1,650,164														420,000
Common stock, par value				$ 0.0001	0.0001	$ 0.0001		$ 0.0001					$ 0.0001					$ 0.0001		$ 0.0001
Offering price				$ 9.50	$ 6.00	$ 6.06		$ 5.00					5.00					5.00		$ 5.00
Proceeds from sale of common stock																				$ 2,100,000
Offering expenses																				168,000
Purchase of additional shares description	(i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater			Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share				Each purchaser also had the right to purchase, on or before October 19, 2020, additional shares of common stock (the “Additional Shares”) equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 1,387,500 shares, at an offering price of $5.00 per share
Proceeds from sale of common stock						$ 10,000,000
Offering expenses						$ 847,619
Shares issued for exercised stock options																				$ 6,817
Shares issued for exercised stock options, shares																				16,669
Securities Purchase Agreement [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued for exercised stock options, shares												13,642
Stock Purchase Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																				1,573,218
Common stock, par value													0.0001					0.0001		$ 0.0001
Offering expenses																				$ 609,010
Cash proceeds																				$ 2,000,000
Investor [Member] | Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued				3,300,001
Number of stock sold								1,850,000	3,157,895	2,200,000
Common stock, par value								$ 0.0001	$ 0.0001	$ 0.0001
Offering price									$ 4.75	$ 2.50			$ 5.00					$ 5.00		$ 5.00
Proceeds from sale of common stock								$ 9,250,000	$ 15,000,000	$ 5,500,000
Offering expenses								$ 740,000	$ 1,249,200	$ 435,000
Number of additional shares purchased								302,500
Investor [Member] | Securities Purchase Agreement [Member] | Additional Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Offering price				$ 11.50
Bridge Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																553,330
Value of common stock issued																$ 600,000
Convertible Bridge Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued during conversion, shares																				1,030,585
Shares issued during conversion																				$ 1,000,000